Home › Trials › NCT03687359

Evaluation of atopic dermatitis in children

Prospective, Observational, Longitudinal Study in Pediatric Patients With Moderate to Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable

Observational Sanofi · NCT03687359

This study looks at children with moderate to severe eczema who aren't getting better with creams to see how the condition affects them and what treatments work best over ten years.

Quick facts

Study typeObservational
Enrollment1845 (estimated)
Ages0 Years to 11 Years
SexAll
SponsorSanofi Industry-sponsored
Locations181 sites (Birmingham, Alabama and 180 other locations)
Trial IDNCT03687359 on ClinicalTrials.gov

What this trial studies

This observational study aims to describe the characteristics of pediatric patients suffering from moderate to severe atopic dermatitis (AD) who are not adequately controlled with topical therapies or for whom such therapies are not advisable. It will evaluate the time-course of AD and associated atopic comorbidities, while also characterizing the disease burden and unmet needs of these patients. Additionally, the study will document real-world treatment patterns, effectiveness, and safety of various treatments over a duration of 120 months.

Who should consider this trial

Good fit: Ideal candidates for this study are pediatric patients with moderate to severe atopic dermatitis currently receiving systemic treatment or those on topical treatment who are candidates for systemic therapy.

Not a fit: Patients who are concurrently participating in an interventional clinical trial that modifies their care will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the management and treatment of pediatric atopic dermatitis, leading to improved patient outcomes.

How similar studies have performed: Other studies have shown success in evaluating atopic dermatitis in pediatric populations, indicating that this approach is supported by prior research.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion criteria:

* Patients with moderate to severe AD, according to the Investigator's assessment;
* Currently receiving systemic treatment (including phototherapy) for atopic dermatitis or currently on topical treatment, but otherwise candidates for systemic treatment.

Exclusion criteria:

* Concurrent participation in an interventional clinical trial which modifies patient care.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Where this trial is running

Birmingham, Alabama and 180 other locations

+131 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Dermatitis Atopic
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.